Amphetamines |
Substrates of the dopamine transporter. Promote the efflux of dopamine from cytosolic vesicles into the synaptic cleft [26]. |
Cocaine |
Blockage of the dopamine transporter, increasing the levels of dopamine in the synaptic cleft [24,25]. |
Opioids |
Activate µ-opioid receptors on GABAergic interneurons in the ventral tegmental area inhibiting them, which in turn disinhibits dopaminergic neurons that release dopamine in the nucleus accumbens [23]. |
Ethanol |
Acts as a pro-drug through its first metabolite acetaldehyde, which reacts with dopamine to form the tetrahydroisoquinoline adduct salsolinol [27], likely an agonist of the µ-opioid receptor [28,29]. Salsolinol activates opioid receptors on GABAergic interneurons in the ventral tegmental area inhibiting them, which in turn disinhibits dopaminergic neurons that release dopamine in the nucleus accumbens [30]. |
Cannabinoids |
Agonists of CB1 and CB2 receptors. Activate CB1 receptors on GABAergic interneurons in the ventral tegmental area, which in turn disinhibits dopaminergic neurons that release dopamine in the nucleus accumbens [31]. |
Nicotine |
Activate α4β2 or α6β2 nicotinic acetylcholine receptors in mesolimbic dopaminergic neurons [32], which promotes the release of dopamine in the nucleus accumbens [33]. |